CrossAssetDataThe Company File
···
ADVB

Advanced Biomed Inc.

Advanced Biomed Inc. is classed by the SEC under Services-Medical Laboratories (industry code 8071), based in Reno, NV. Its latest filed balance sheet (2025-06-30) shows total assets of $11 million (its filed statements).

Usage business Services-Medical Laboratories Reno, NV filings since 2022 2 of 9 filed, 7 estimated
Ask the desk about ADVB → Compare ADVB with BGLC → Price chart on TradingView ↗ Full EDGAR file ↗ Watch ADVB →

Sector peers: BGLCACONYDESAMS

4.9/10headline grade
vs its business-model standard
4.0/10past 5.0/10present 5.7/10future

Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a usage business: prior from its industry code (SEC 8071, Services-Medical Laboratories); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.

The grade, in three tenses

Headline 4.9 out of ten, 2 of 9 metrics filed and 7 estimated: past 4.0 out of ten, present 5.0 out of ten, future 5.7 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.

The nine metrics

  • Surviving crises (past): 1.3 out of ten. 5 warning events since 2022; the latest 2026-09-28. 13th percentile among 27 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Track record (past): 4.7 out of ten. CrossAssetData estimate 4.7/10, confidence 20 of 100 (family median). 50th percentile among 23 sector filers. A CrossAssetData estimate, not a filed reading: family median, confidence 20 of 100; its next annual report on file with the inputs replaces this estimate with the filed reading.
  • Shareholder treatment (past): 6.6 out of ten. CrossAssetData estimate 6.6/10, confidence 35 of 100 (one part). 66th percentile among 24 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
  • Financial health (present): 4.3 out of ten. ROE -94%: lost 94¢ per shareholder dollar. Leverage 47%: owes 47¢ per asset dollar. 43rd percentile among 25 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Industry position (present): 5.0 out of ten. CrossAssetData estimate 5.0/10, confidence 20 of 100 (family median). 50th percentile among 23 sector filers. A CrossAssetData estimate, not a filed reading: family median, confidence 20 of 100; its next annual report on file with the inputs replaces this estimate with the filed reading.
  • Leadership (present): 6.0 out of ten. CrossAssetData estimate 6.0/10, confidence 20 of 100 (family median). 50th percentile among 20 sector filers. A CrossAssetData estimate, not a filed reading: family median, confidence 20 of 100; its next annual report on file with the inputs replaces this estimate with the filed reading.
  • Room to expand (future): 8.3 out of ten. CrossAssetData estimate 8.3/10, confidence 35 of 100 (one part). 83rd percentile among 26 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
  • Growth drivers (future): 5.3 out of ten. CrossAssetData estimate 5.3/10, confidence 20 of 100 (family median). 50th percentile among 23 sector filers. A CrossAssetData estimate, not a filed reading: family median, confidence 20 of 100; its next annual report on file with the inputs replaces this estimate with the filed reading.
  • Expectations vs reality (future): 4.7 out of ten. CrossAssetData estimate 4.7/10, confidence 20 of 100 (family median). 50th percentile among 20 sector filers. A CrossAssetData estimate, not a filed reading: family median, confidence 20 of 100; its next annual report on file with the inputs replaces this estimate with the filed reading.

The filing record

Newest annual report: Form 10-K filed 2025-10-08 for the period ended 2025-06-30 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-05-15 for the period ended 2026-03-31 (on EDGAR). Newest filing: Form NT 10-K, 2026-09-28. Filings on record since 2022. Read from EDGAR 2026-10-12.

This file: Overview · Past · Present · Future · Filings · every company on file

Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.